STOCK TITAN

Boon’s Processing Facility Up and Running $78M Annual Capacity

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Boon Industries, Inc. (OTC PINK: BNOW) has completed its production facility in Grass Valley, gaining a certified Good Manufacturing Practice (cGMP) status. The facility can produce over 1,000 gallons of BioDox per day, generating approximately $300,000 in daily revenue, equating to an annual potential of $78 million. Boon anticipates increased sales due to its cGMP status and aims to penetrate further into agricultural and pending EPA-compliant markets, contributing to ongoing revenue growth.

Positive
  • Completion of production facility.
  • Certification of Good Manufacturing Practice (cGMP) status.
  • Production capacity of over 1,000 gallons of BioDox per day, translating to approx. $300,000 daily revenue.
  • Annual revenue potential of approximately $78 million under current demand.
  • Strong customer acquisition ratio of 1:2 indicates successful customer retention.
Negative
  • None.

Boon's production facility is complete and sees an increase in new orders as a result of its newly certified Good Manufacturing Practices

SACRAMENTO, CA, March 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Boon Industries, Inc. (OTC PINK: BNOW) (“Boon” or the “Company”), an environmentally conscious bioscience company delivering solutions that benefit people and the planet, is pleased to announce that its  production facility is complete, and an increase in new orders as a result of its newly certified Good Manufacturing Practice (cGMP) status for its production facility in Grass Valley.

Justin Gonzalez, Chairman, stated, “The new facility will produce over one thousand gallons of BioDox or Diox+ per day, which represents revenue of approximately $300,000 per day. This allows for an annual revenue to meet demand of approximately $78M before expansion would be required.  BioDox is bottled in a concentrated formula that is sold by the quart for $89 or by the gallon for $229.

This escalation in sales validates and aligns with Boon Industries’ belief that the cGMP status stimulates and expedites ongoing anchor level relationships. Boon’s customer acquisition costs and ratio to establishing new customers is 1:2. The customers are repeat and will purchase an estimated $.50 per sq ft of BioDox. The farms range from 10,000 sq. ft. to 10,000 acres.

Mr. Gonzalez further stated, “The agriculture markets allow Boon to generate sales as a 25(b) product while waiting for EPA approval for other applications, and Boon is currently developing sales in these markets. We believe our current success in the agriculture industry will be relative to the pending EPA compliant industries such as medical, hospitality and warehousing that as the Company accomplishes these compliance milestones we will continue to see an increase of revenue from larger distributors for our products as we expand into new markets.”

About Boon Industries

Boon Industries, Inc. (OTC:BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon’s product offering is DiOx+™ and BioDox™ , a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind Boon’s products make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. BioDox™ helps prevent agricultural crops from disease. Diox+™  is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon’s CEO Justin Gonzalez. DiOx+ delivers on Boon’s promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon’s manufacturing facility and corporate headquarters in Grass Valley, California.

Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Please note that from time to time the Company may post new information at its website boonindustries.com, or via its current social media accounts below:

LinkedIn: https://www.linkedin.com/company/boon-industries

Twitter: https://twitter.com/boonindustries

The Company’s most current Investor Presentation is available at the following link:

www.BoonIndustries.com/deck

Company Contact

Boon Industries, Inc.

www.boonindustries.com

admin@boonindustries.com


Investor Relations & Financial Media

Integrity Media Inc.

team@integritymedia.com

Toll Free: (888) 216-3595

www.IntegrityMedia.com



FAQ

What recent development has Boon Industries (BNOW) announced?

Boon Industries has announced the completion of its production facility and received Good Manufacturing Practice (cGMP) certification.

What is the production capacity of Boon Industries' new facility?

The new facility can produce over 1,000 gallons of BioDox per day.

How much revenue can Boon Industries generate from its new production facility?

Boon Industries estimates it can generate approximately $300,000 in daily revenue, leading to around $78 million annually.

What markets is Boon Industries targeting with its products?

Boon Industries is targeting agricultural markets and is developing sales in pending EPA-compliant industries like medical and hospitality.

What does the Good Manufacturing Practice (cGMP) certification mean for Boon Industries?

The cGMP certification enhances Boon Industries' credibility and is expected to attract more customers and increase sales.

BNOW

OTC:BNOW

BNOW Rankings

BNOW Latest News

BNOW Stock Data

73.42M
7.7%
Chemicals
Basic Materials
Link
United States
Grass Valley